| 标题： | HIV耐药检测及临床管理专家共识 |
| title： | Expert Consensus on HIV Drug Resistance Testing and Clinical Management |
| 版本： | 原创版 |
| version： | Original |
| 分类： | 专家共识 |
| classification： | Experts consensus |
| 领域： | 诊疗 |
| field： | Diagnosis and Treatment |
| 国家和地区： | 中国 |
| Country and region： | China |
| 指南使用者： | 临床工作者，尤其感染性疾病专科或者HIV感染专科诊疗工作者。 |
| Guide users： | Clinical workers, especially those specialized in infectious diseases or HIV infection. |
| 证据分级方法： | 推荐强度：A：强烈推荐，B：中等推荐，C：可选。 与之对应的证据级别：I：至少一项随机对照研究或荟萃分析，Ⅱ：至少一项非随机研究或观察队列研究，Ⅲ：专家意见。 |
| Evidence grading method： | Recommendation Strengths: A: Strongly recommended B: Moderately recommended C: Optional Corresponding Levels of Evidence: I: At least one randomized controlled trial or a meta-analysis II: At least one non-randomized study or observational cohort study III: Expert opinion |
| 制定单位： | 浙江大学医学院附属第一医院 |
| Formulating unit： | First Affiliated Hospital, Zhejiang University School of Medicine |
| 注册时间： | 2024-10-30 |
| Registration time： | |
| 注册编号： | PREPARE-2024CN971 |
| Registration number： | |
| 指南制订的目的： | 随着抗逆转录病毒治疗的广泛开展，HIV的耐药性问题也逐渐引起大家的关注。什么时机采取何种HIV耐药性检测，临床上如何避免HIV耐药性的产生和传播，是目前亟待解决的问题。本共识将全面回顾HIV耐药检测及临床管理的相关文献，并结合专家建议对HIV耐药性检测的相关内容做总结，并给出相应的处理建议。 |
| Purpose of the guideline： | With the widespread of antiretroviral therapy, the issue of HIV drug resistance has gradually attracted people's attention. The timing and method of HIV drug resistance testing, as well as how to avoid the emergence and spread of HIV drug resistance in clinical practice, are urgent issues that need to be addressed. This consensus will comprehensively review the relevant literature on HIV drug resistance testing and clinical management, and summarize the relevant content of HIV drug resistance testing based on expert recommendations, and provide corresponding treatment suggestions. |
最新注册
